Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers

NCT01710605 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Ductal Infiltrating Metastatic Breast Cancer
Hormone-receptors Positive Breast Cancer

Interventions

BIOLOGICAL: Circulating tumor cells counting at baseline

Sponsor

Institut Curie